However, in most cases, DPP4 inhibitor users had other medications for T2DM like metformin, renin-angiotensin system inhibitors, thiazolidinediones, diuretics, or statin, making it difficult to attribute the beneficial effect solely to DPP4 inhibitors [145]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.